Femme et Homme
- | Pays :
- Hungary
- France
- Bulgaria
- Les 13 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is an open-label, randomized, controlled, multi-national, multi-center, parallel-arm trial comparing tivozanib to sorafenib in subjects with advanced RCC. The study is designed to compare the PFS, OS, ORR, DR, safety and tolerability, and kidney specific symptoms/health outcome measurements of tivozanib and sorafenib.
Critère d'inclusion
- ADVANCED RENAL CELL CARCINOMA